MARIUPOL (Sputnik) -According to documents obtained by Sputnik, major Western pharmaceutical companies, with the assistance of Ukrainian officials, purportedly conducted testing of rheumatological drugs on patients in a Mariupol psychiatric ward for several years.
During the restoration of hospital No. 7 in Mariupol, a construction team stumbled upon a collection of documents in the basement.
These findings of interest turned out to be records from a hospital psychiatric ward, dating from 2008 to 2016. Upon examination, these documents detailed a series of human experiments involving certain undisclosed drugs, which were solely identified by numbers.
Brain Wallpaper – Sputnik International, 1920, 16.06.2022
Russia’s Special Operation in Ukraine
16 June 2022, 15:32 GMT
The primary purpose of the research was to evaluate the effectiveness of the drug in relation to the proportion of patients who achieved the response according to the criteria of the American College of Rheumatology (ACR).
Such companies like Pfizer, AstraZeneca, Celltrion, Novatris International AG, IQVIA, Sanofi, Galapagos NV, Janssen Pharmaceuticals, AbbottLaboratories, Covance, Merck KGaA, CentocorBiopharmaceutical and a branch of Samsung that produces medical equipment were mentioned in the documents.
In addition, boxes containing many ready-made envelopes from logistics companies and containers for biomaterial with recipient addresses of laboratories in Switzerland, the United Kingdom and the United States were found on the site of the hospital.
A member of the US Army Technical Escort Unit (TSU) demonstrates a hazmat suit as they show some of their response capabilities to chemical and biologicial operations in support of the US Department of Defense, federal, state, and local agencies 12 November 2002 – Sputnik International, 1920, 13.11.2023
13 November 2023, 14:01 GMT
Published by Sputnik Globe
Republished by The 21st Century
The views expressed in this article are solely those of the author and do not necessarily reflect the opinions of 21cir.com.